Prof. Giannaccare | Reducing Iatrogenic Ocular Surface Disease in Glaucoma Patients Through Light Modulation™ LLLT

In this webinar, Prof. Giannaccare outlines the role of Light Modulation™ Low-Level Light Therapy (PBM) in managing and preventing ocular surface disease.

He reviews the impact of topical glaucoma medications and shows how LLLT supports better ocular surface health and patient comfort.

Key Takeaways:

• How topical treatments can induce ocular surface damage
• LLLT’s biological effects that promote healing
• Clinical evidence showing improvements in tear film, corneal health, and symptoms

Learn how adding LLLT to clinical practice can optimize outcomes for patients at risk of ocular surface disease.

The event will be followed by a LIVE Q&A session with Espansione's Medical Affairs Team.

Can't join the live session? Sign up anyway, we'll send you the replay!